201 related articles for article (PubMed ID: 2570957)
1. Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid.
Lindsjö M; Fellström B; Ljunghall S; Wikström B; Danielson BG
Lancet; 1989 Sep; 2(8665):701-4. PubMed ID: 2570957
[TBL] [Abstract][Full Text] [Related]
2. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
3. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
Takei K; Ito H; Masai M; Kotake T
Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
[TBL] [Abstract][Full Text] [Related]
4. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
Espino-Grosso P; Monsour C; Canales BK
Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
[TBL] [Abstract][Full Text] [Related]
6. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
Langman CB; Grujic D; Pease RM; Easter L; Nezzer J; Margolin A; Brettman L
Am J Nephrol; 2016; 44(2):150-8. PubMed ID: 27529510
[TBL] [Abstract][Full Text] [Related]
7. [Hyperoxaluria and renal calculi].
Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
[TBL] [Abstract][Full Text] [Related]
8. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
9. Urinary outputs of oxalate, calcium, and magnesium in children with intestinal disorders. Potential cause of renal calculi.
Ogilvie D; McCollum JP; Packer S; Manning J; Oyesiku J; Muller DP; Harries JT
Arch Dis Child; 1976 Oct; 51(10):790-5. PubMed ID: 1008583
[TBL] [Abstract][Full Text] [Related]
10. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
Jaeger P; Portmann L; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
[TBL] [Abstract][Full Text] [Related]
11. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
[TBL] [Abstract][Full Text] [Related]
12. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
[TBL] [Abstract][Full Text] [Related]
13. ALLN-177, oral enzyme therapy for hyperoxaluria.
Lingeman JE; Pareek G; Easter L; Pease R; Grujic D; Brettman L; Langman CB
Int Urol Nephrol; 2019 Apr; 51(4):601-608. PubMed ID: 30783888
[TBL] [Abstract][Full Text] [Related]
14. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
Hatch M
Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
[TBL] [Abstract][Full Text] [Related]
15. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
Marangella M; Fruttero B; Bruno M; Linari F
Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
[TBL] [Abstract][Full Text] [Related]
16. Use of a probiotic to decrease enteric hyperoxaluria.
Lieske JC; Goldfarb DS; De Simone C; Regnier C
Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
18. Enteric hyperoxaluria.
Earnest DL
Adv Intern Med; 1979; 24():407-27. PubMed ID: 371365
[No Abstract] [Full Text] [Related]
19. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
[TBL] [Abstract][Full Text] [Related]
20. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
Langman CB; Assimos D; Blank M; Calle J; Grauer A; Kausz A; Milliner D; Nazzal L; Smith K; Tasian G; Thompson A; Wood KD; Worcester E; Yang S; Malley MA; Knauf F; Lieske JC;
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1637-1644. PubMed ID: 37342976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
